Brief: Exagen Inc. Outlook Q3 Revenue USD 10-10.5 Mln
07/08/2023 13:03
Aug 7 (Reuters) - Exagen Inc. Outlook Q3 revenue USD 10-10.5 million. * Q2 basic EPS USD -0.28 * Q2 revenue USD 14.1 million vs. IBES estimate USD 10.9 million * Q2 net income USD -5 million * Q2 gross margin 58.7% * Q2 operating expenses USD 19.1 million * Q2 income from operations USD -4.915 million
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance